CN103272192A - Medicament for treating perianal abscess - Google Patents

Medicament for treating perianal abscess Download PDF

Info

Publication number
CN103272192A
CN103272192A CN2013100802879A CN201310080287A CN103272192A CN 103272192 A CN103272192 A CN 103272192A CN 2013100802879 A CN2013100802879 A CN 2013100802879A CN 201310080287 A CN201310080287 A CN 201310080287A CN 103272192 A CN103272192 A CN 103272192A
Authority
CN
China
Prior art keywords
parts
herba
radix
medicament
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100802879A
Other languages
Chinese (zh)
Other versions
CN103272192B (en
Inventor
王敬源
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310080287.9A priority Critical patent/CN103272192B/en
Publication of CN103272192A publication Critical patent/CN103272192A/en
Application granted granted Critical
Publication of CN103272192B publication Critical patent/CN103272192B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating the perianal abscess. The medicament is prepared through using Radix Scrophulariae, dry ginger, Cornus officinalis, Radix Platycodonis, dahurian angelica root, Flos Inulae, Vaccaria segetalis, Herba Aristolochiae, Divaricate Saposhnikovia Root, Herbal Ephedrae, Fructus Terminaliae Billericae, Radix Morindae officinalis, Greater Celandine Herb, Pericarpium Arecae, Siberian Cocklour Fruit, Phyllanthus emblica, Murraya exotica L., Thallus Laminariae, Herba Inulae, Glabrous Sarcandra Herb, Herba Clinopodii, Folium Sennae, Aleppo Avens, Radix Rhapontici, Solidago decurrens, Potentilla Discolor Bunge, Calyx seu fructus Physalis, White Mulberry Root-bark, Lindley Eupatorium Herb, Himalayan Teasel Root and Rhododendron molle. All components of the medicament for treating the perianal abscess are natural materials, so the medicament has a good safety and a clear curative effect, and is suitable for the clinic large-scale popularization.

Description

A kind of medicament for the treatment of perianal abscess
Technical field
The present invention relates to the anorectal surgical field, relate in particular to a kind of medicament for the treatment of perianal abscess.
Background technology
Perianal abscess be exactly around the anus subcutaneous abscess draw modal disease, how outwards or directly to be formed to external diffusion through the external sphincter subcutaneous part by the anal gland infection.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of perianal abscess.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of perianal abscess, it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Pericarpium Arecae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Thallus Laminariae (Thallus Eckloniae) 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Herba Solidaginis 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of perianal abscess of the present invention is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts in Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Pericarpium Arecae, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Thallus Laminariae (Thallus Eckloniae)s, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Herba Solidaginiss, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of perianal abscess of the present invention all are natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment decoction of the present invention
Take by weighing Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Pericarpium Arecae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Thallus Laminariae (Thallus Eckloniae) 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Herba Solidaginis 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Radix Dipsaci 16 grams and Flos Rhododendri Mollis 24 grams, add water 2500 milliliters, in the flask of condensing tube is housed, heated 5 hours down at 90 ℃, filter.Filtrate is concentrated into 900 milliliters, namely gets decoction of the present invention.
Experimental example
Clinical data
According to Huang Naijian. Chinese anorectal disease is learned [M]. and Jinan: the .1996:60 of Shandong science tech publishing house selects patient to be treated.90 routine patients all are chosen for the abscess initial stage (abscess is not completed into as yet), the area size that swells and ache 0.5cm * 0.5cm to 5cm * 4cm, average 2.0cm * 1.5cm; The blood leukocytes sum increases 10 * 10 9/ L to 1.6 * 10 9/ L person accounts for 40%, and the normal person of total white blood cells accounts for 60%.Male's 56 examples, women's 34 examples; Age 16-56 year, average 33.30 years old; Course of disease 3-10d, average 5.50d.
Therapeutic Method: use the decoction of preparation among the embodiment 1 to treat, every day 3 times, each oral 80 milliliters.Treating 10 days is 1 course for the treatment of.
Efficacy evaluation
According to Huang Naijian. Chinese anorectal disease is learned [M]. and Jinan: the .1996:60 of Shandong science tech publishing house works out efficacy evaluation.Cure: transference cure, the abscess lump is eliminated; Take a turn for the better: doing well,improving, the abscess lump alleviates; Do not heal: the equal no change of sings and symptoms, or the state of an illness further develops.
Through the treatment of 1 course for the treatment of, find to cure 81 examples among the 90 routine patients, 9 examples take a turn for the better.

Claims (3)

1. medicament for the treatment of perianal abscess, it is characterized in that it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Pericarpium Arecae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Thallus Laminariae (Thallus Eckloniae) 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Herba Solidaginis 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of perianal abscess according to claim 1, it is characterized in that it is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts in Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Pericarpium Arecae, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Thallus Laminariae (Thallus Eckloniae)s, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Herba Solidaginiss, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
3. the medicament for the treatment of perianal abscess according to claim 1 is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
CN201310080287.9A 2013-03-14 2013-03-14 Medicament for treating perianal abscess Expired - Fee Related CN103272192B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310080287.9A CN103272192B (en) 2013-03-14 2013-03-14 Medicament for treating perianal abscess

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310080287.9A CN103272192B (en) 2013-03-14 2013-03-14 Medicament for treating perianal abscess

Publications (2)

Publication Number Publication Date
CN103272192A true CN103272192A (en) 2013-09-04
CN103272192B CN103272192B (en) 2014-08-06

Family

ID=49054554

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310080287.9A Expired - Fee Related CN103272192B (en) 2013-03-14 2013-03-14 Medicament for treating perianal abscess

Country Status (1)

Country Link
CN (1) CN103272192B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709084A (en) * 2016-01-29 2016-06-29 林鸿 External preparation for treating perianal abscess and preparation method of external preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857501A (en) * 2006-03-13 2006-11-08 叶明伟 Fumigant for treating perianal abscess and its preparing method
CN101234173A (en) * 2008-03-04 2008-08-06 朱长远 Medicament for treating perianal abscess and preparation thereof
CN102526694A (en) * 2012-03-14 2012-07-04 刘晓枫 Lotion beneficial to health of anus and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857501A (en) * 2006-03-13 2006-11-08 叶明伟 Fumigant for treating perianal abscess and its preparing method
CN101234173A (en) * 2008-03-04 2008-08-06 朱长远 Medicament for treating perianal abscess and preparation thereof
CN102526694A (en) * 2012-03-14 2012-07-04 刘晓枫 Lotion beneficial to health of anus and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709084A (en) * 2016-01-29 2016-06-29 林鸿 External preparation for treating perianal abscess and preparation method of external preparation

Also Published As

Publication number Publication date
CN103272192B (en) 2014-08-06

Similar Documents

Publication Publication Date Title
CN102028842B (en) Medicament for treating dysmenorrhea and preparation method thereof
CN101897868B (en) Chinese medicinal composition for treating psoriasis and preparation method thereof
CN101543558A (en) Medicine composition for treating facioplegia and preparation method thereof
CN103142959A (en) Medicament for treating urticaria
CN103272192B (en) Medicament for treating perianal abscess
CN103142982A (en) Medicine for treating acute upper respiratory infection
CN1247086A (en) Process for making medical wine for treating rheumatism
CN101658636B (en) Chinese medical composition for treating coronary heart disease
CN101843861B (en) Chinese medicinal composition for treating tonsillitis
CN103908578A (en) Preparation method of drug for treating postpartum acute hemorrhoid
CN100369625C (en) Externally applied medicinal ointment for treating scald and burn
CN103055055A (en) Traditional Chinese medicine for treating skin diseases
CN103341044B (en) Itching-relieving compound preparation and preparation method thereof
CN102294007A (en) Medicament for treating urticaria
CN103550516B (en) A kind of preparation method for the treatment of the medicament of perianal abscess
CN103157091A (en) Drug for treating empyrosis
CN103142958A (en) Medicament for treating perniosis
CN104415252A (en) Traditional Chinese medicine water decoction for treating ichthyosis
CN103157090A (en) Medicament for treating diarrhea
CN103142972B (en) Medicine for treating children dermatosis
CN103341021A (en) Radiationproof Chinese herbal preparation for ultrasound department and preparation method of radiationproof Chinese herbal preparation
CN103272193A (en) Medicament for treating mammary gland hyperplasia
CN103142960B (en) Medicament for treating skin diseases
CN103142977A (en) Medicament for treating dysmenorrhea
CN103142984B (en) Medicine for treating rheumatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140806

Termination date: 20150314

EXPY Termination of patent right or utility model